Biotechnological medicinal products offer great opportunities for up to now incurable diseases. Hence, they represent nowadays a significant and growing market. Nevertheless their heterogeneity still remain a big challenge. A major challenge with biopharmaceuticals is their heterogeneity. ... more
Prof. Dr. Chrystelle Mavoungou
Hochschule Biberach, Fakultät für Pharmazeutische Biotechnologie
Chrystelle Mavoungou, chemist, obtained her Ph.D in the Department of Structural Biology at the Max Planck Institute for Biochemistry in Martinsried. Here she specialised in methods for determination of protein structures with 2D and 3D NMR spectroscopy and ligand-binding studies using molecular dynamics simulation. She worked at ratiopharm GmbH in Ulm, as Regulatory Affairs Manager for seven years. There she acquired comprehensive knowledge of pharmaceutical regulatory processes, which also covered pharmaceutical manufacturing in a GMP environment. She was appointed Professor and Head of the Department of Quality in Pharmaceutical Manufacturing at Biberach University in 2010.